{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T05:30:44Z","timestamp":1745386244948},"reference-count":29,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,6,16]]},"DOI":"10.7759\/cureus.40511","type":"journal-article","created":{"date-parts":[[2023,6,16]],"date-time":"2023-06-16T13:45:08Z","timestamp":1686923108000},"source":"Crossref","is-referenced-by-count":1,"title":["Impaired Thiamine Metabolism in Amyotrophic Lateral Sclerosis and Its Potential Treatment With Benfotiamine: A Case Report and a Review of the Literature"],"prefix":"10.7759","author":[{"given":"Richard H","family":"Mann","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuint.2004.05.007","article-title":"Tricarboxylic acid cycle enzymes following thiamine deficiency","volume":"45","author":"Bubber P","year":"2004","unstructured":"Bubber P, Ke ZJ, Gibson GE. Tricarboxylic acid cycle enzymes following thiamine deficiency. Neurochem Int. 2004, 45:1021-8. 10.1016\/j.neuint.2004.05.007","journal-title":"Neurochem Int"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1007\/s12035-016-0079-9","article-title":"Thiamine deficiency and neurodegeneration: the interplay among oxidative stress, endoplasmic reticulum stress, and autophagy","volume":"54","author":"Liu D","year":"2017","unstructured":"Liu D, Ke Z, Luo J. Thiamine deficiency and neurodegeneration: the interplay among oxidative stress, endoplasmic reticulum stress, and autophagy. Mol Neurobiol. 2017, 54:5440-8. 10.1007\/s12035-016-0079-9","journal-title":"Mol Neurobiol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1177\/1533210110392941","article-title":"Thiamine (vitamin B1)","volume":"16","author":"Fattal-Valevski A","year":"2011","unstructured":"Fattal-Valevski A. Thiamine (vitamin B1). J Evid Based Complementary Altern Med. 2011, 16:12-20. 10.1177\/1533210110392941","journal-title":"J Evid Based Complementary Altern Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1111\/imj.12522","article-title":"Thiamine in the treatment of Wernicke encephalopathy in patients with alcohol use disorders","volume":"44","author":"Latt N","year":"2014","unstructured":"Latt N, Dore G. Thiamine in the treatment of Wernicke encephalopathy in patients with alcohol use disorders. Intern Med J. 2014, 44:911-5. 10.1111\/imj.12522","journal-title":"Intern Med J"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1046\/j.1471-4159.1997.69052005.x","article-title":"Low thiamine diphosphate levels in brains of patients with frontal lobe degeneration of the non-Alzheimer's type","volume":"69","author":"Bettendorff L","year":"1997","unstructured":"Bettendorff L, Mastrogiacomo F, Wins P, Kish SJ, Grisar T, Ball MJ. Low thiamine diphosphate levels in brains of patients with frontal lobe degeneration of the non-Alzheimer's type. J Neurochem. 1997, 69:2005-10. 10.1046\/j.1471-4159.1997.69052005.x","journal-title":"J Neurochem"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2013-009289","article-title":"High-dose thiamine as initial treatment for Parkinson's disease","volume":"2013","author":"Costantini A","year":"2013","unstructured":"Costantini A, Pala MI, Compagnoni L, Colangeli M. High-dose thiamine as initial treatment for Parkinson's disease. BMJ Case Rep. 2013, 2013:2013009289. 10.1136\/bcr-2013-009289","journal-title":"BMJ Case Rep"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2013-009424","article-title":"High-dose thiamine improves the symptoms of Friedreich's ataxia","volume":"2013","author":"Costantini A","year":"2013","unstructured":"Costantini A, Giorgi R, D'Agostino S, Pala MI. High-dose thiamine improves the symptoms of Friedreich's ataxia. BMJ Case Rep. 2013, 2013:2013009424. 10.1136\/bcr-2013-009424","journal-title":"BMJ Case Rep"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2012-007302","article-title":"Thiamine and spinocerebellar ataxia type 2","volume":"2013","author":"Costantini A","year":"2013","unstructured":"Costantini A, Pala MI, Colangeli M, Savelli S. Thiamine and spinocerebellar ataxia type 2. BMJ Case Rep. 2013, 2013:2012007302. 10.1136\/bcr-2012-007302","journal-title":"BMJ Case Rep"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(93)91554-6","article-title":"Decreased activities of thiamine diphosphatase in frontal and temporal cortex in Alzheimer's disease","volume":"631(2)","author":"Rao VL","year":"1993","unstructured":"Rao VL, Richardson JS, Butterworth RF. Decreased activities of thiamine diphosphatase in frontal and temporal cortex in Alzheimer's disease. Brain Res. 1993, 631(2):334-6. 10.1016\/0006-8993(93)91554-6","journal-title":"Brain Res"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.1988.00520320022009","article-title":"Reduced activities of thiamine-dependent enzymes in the brains and peripheral tissues of patients with Alzheimer's disease","volume":"45","author":"Gibson GE","year":"1988","unstructured":"Gibson GE, Sheu KF, Blass JP, Baker A, Carlson KC, Harding B, Perrino P. Reduced activities of thiamine-dependent enzymes in the brains and peripheral tissues of patients with Alzheimer's disease. Arch Neurol. 1988, 45:836-40. 10.1001\/archneur.1988.00520320022009","journal-title":"Arch Neurol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2015.11.039","article-title":"Measurement of blood thiamine metabolites for Alzheimer\u2019s disease diagnosis","volume":"3","author":"Pan X","year":"2016","unstructured":"Pan X, Fei G, Lu J, et al.. Measurement of blood thiamine metabolites for Alzheimer\u2019s disease diagnosis. EBioMedicine. 2016, 3:155-62. 10.1016\/j.ebiom.2015.11.039","journal-title":"EBioMedicine"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1007\/s12264-016-0067-0","article-title":"Long-term cognitive improvement after benfotiamine administration in patients with Alzheimer's disease","volume":"32","author":"Pan X","year":"2016","unstructured":"Pan X, Chen Z, Fei G, et al.. Long-term cognitive improvement after benfotiamine administration in patients with Alzheimer's disease. Neurosci Bull. 2016, 32:591-6. 10.1007\/s12264-016-0067-0","journal-title":"Neurosci Bull"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.34297\/AJBSR.2019.03.000621","article-title":"Thiamine deficiency and benfotiamine therapy in brain diseases","volume":"3","author":"Pavlovi\u0107 DM","year":"2019","unstructured":"Pavlovi\u0107 DM. Thiamine deficiency and benfotiamine therapy in brain diseases. Am J Biomed Sci Res. 2019, 3:1. 10.34297\/AJBSR.2019.03.000621","journal-title":"Am J Biomed Sci Res"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.3233\/JAD-200896","article-title":"Benfotiamine and cognitive decline in Alzheimer's disease: results of a randomized placebo-controlled phase IIa clinical trial","volume":"78","author":"Gibson GE","year":"2020","unstructured":"Gibson GE, Luchsinger JA, Cirio R, et al.. Benfotiamine and cognitive decline in Alzheimer's disease: results of a randomized placebo-controlled phase IIa clinical trial. J Alzheimers Dis. 2020, 78:989-1010. 10.3233\/JAD-200896","journal-title":"J Alzheimers Dis"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1002\/biof.5520110132","article-title":"Biokinetic parameters and metabolism of S-benzoylthiamine-O-monophosphate","volume":"11","author":"Ziems M","year":"2000","unstructured":"Ziems M, Netzel M, Bitsch I. Biokinetic parameters and metabolism of S-benzoylthiamine-O-monophosphate. Biofactors. 2000, 11:109-10. 10.1002\/biof.5520110132","journal-title":"Biofactors"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1055\/s-2008-1065351","article-title":"Benfotiamine in diabetic polyneuropathy (BENDIP): results of a randomised, double blind, placebo-controlled clinical study","volume":"116","author":"Stracke H","year":"2008","unstructured":"Stracke H, Gaus W, Achenbach U, Federlin K, Bretzel RG. Benfotiamine in diabetic polyneuropathy (BENDIP): results of a randomised, double blind, placebo-controlled clinical study. Exp Clin Endocrinol Diabetes. 2008, 116:600-5. 10.1055\/s-2008-1065351","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1093\/alcalc\/33.6.631","article-title":"Benfotiamine in treatment of alcoholic polyneuropathy: an 8-week randomized controlled study (BAP I Study)","volume":"33","author":"Woelk H","year":"1998","unstructured":"Woelk H, Lehrl S, Bitsch R, K\u00f6pcke W. Benfotiamine in treatment of alcoholic polyneuropathy: an 8-week randomized controlled study (BAP I Study). Alcohol Alcohol. 1998, 33:631-8. 10.1093\/alcalc\/33.6.631","journal-title":"Alcohol Alcohol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/0022-510x(92)90162-e","article-title":"Thiamin mono- and pyrophosphatase activities from brain homogenate of Guamanian amyotrophic lateral sclerosis and parkinsonism-dementia patients","volume":"109","author":"Laforenza U","year":"1992","unstructured":"Laforenza U, Patrini C, Poloni M, Mazzarello P, Ceroni M, Gajdusek DC, Garruto RM. Thiamin mono- and pyrophosphatase activities from brain homogenate of Guamanian amyotrophic lateral sclerosis and parkinsonism-dementia patients. J Neurol Sci. 1992, 109:156-61. 10.1016\/0022-510x(92)90162-e","journal-title":"J Neurol Sci"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.1982.00510200049009","article-title":"Thiamin monophosphate in the CSF of patients with amyotrophic lateral sclerosis","volume":"39","author":"Poloni M","year":"1982","unstructured":"Poloni M, Patrini C, Rocchelli B, Rindi G. Thiamin monophosphate in the CSF of patients with amyotrophic lateral sclerosis. Arch Neurol. 1982, 39:507-9. 10.1001\/archneur.1982.00510200049009","journal-title":"Arch Neurol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2014-309435","article-title":"Thiamine deficiency in amyotrophic lateral sclerosis","volume":"86","author":"Jesse S","year":"2015","unstructured":"Jesse S, Thal DR, Ludolph AC. Thiamine deficiency in amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry. 2015, 86:1166-8. 10.1136\/jnnp-2014-309435","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1111\/j.1742-4658.2009.07019.x","article-title":"Thiamin diphosphate in biological chemistry: new aspects of thiamin metabolism, especially triphosphate derivatives acting other than as cofactors","volume":"276","author":"Bettendorff L","year":"2009","unstructured":"Bettendorff L, Wins P. Thiamin diphosphate in biological chemistry: new aspects of thiamin metabolism, especially triphosphate derivatives acting other than as cofactors. FEBS J. 2009, 276:2917-25. 10.1111\/j.1742-4658.2009.07019.x","journal-title":"FEBS J"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.2174\/157339905774574383","article-title":"The potential role of thiamine (vitamin B1) in diabetic complications","volume":"1","author":"Thornalley PJ","year":"2005","unstructured":"Thornalley PJ. The potential role of thiamine (vitamin B1) in diabetic complications. Curr Diabetes Rev. 2005, 1:287-98. 10.2174\/157339905774574383","journal-title":"Curr Diabetes Rev"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/j.ncl.2013.02.002","article-title":"Nutritional neuropathies","volume":"31","author":"Hammond N","year":"2013","unstructured":"Hammond N, Wang Y, Dimachkie MM, Barohn RJ. Nutritional neuropathies. Neurol Clin. 2013, 31:477-89. 10.1016\/j.ncl.2013.02.002","journal-title":"Neurol Clin"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2022.113986","article-title":"In FUS[1-359]-tg mice O,S-dibenzoyl thiamine reduces muscle atrophy, decreases glycogen synthase kinase 3 beta, and normalizes the metabolome","volume":"156","author":"Probert F","year":"2022","unstructured":"Probert F, Gorlova A, Deikin A, et al.. In FUS[1-359]-tg mice O,S-dibenzoyl thiamine reduces muscle atrophy, decreases glycogen synthase kinase 3 beta, and normalizes the metabolome. Biomed Pharmacother. 2022, 156:113986. 10.1016\/j.biopha.2022.113986","journal-title":"Biomed Pharmacother"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuint.2010.11.019","article-title":"Modeling neurodegenerative disease pathophysiology in thiamine deficiency: consequences of impaired oxidative metabolism","volume":"58","author":"Jhala SS","year":"2011","unstructured":"Jhala SS, Hazell AS. Modeling neurodegenerative disease pathophysiology in thiamine deficiency: consequences of impaired oxidative metabolism. Neurochem Int. 2011, 58:248-60. 10.1016\/j.neuint.2010.11.019","journal-title":"Neurochem Int"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.3390\/nu13113804","article-title":"Nutrient effects on motor neurons and the risk of amyotrophic lateral sclerosis","volume":"13","author":"Goncharova PS","year":"2021","unstructured":"Goncharova PS, Davydova TK, Popova TE, et al.. Nutrient effects on motor neurons and the risk of amyotrophic lateral sclerosis. Nutrients. 2021, 13:10.3390\/nu13113804","journal-title":"Nutrients"},{"key":"ref27","article-title":"Fragmentation of the Golgi apparatus of motor neurons in amyotrophic lateral sclerosis","volume":"140","author":"Gonatas NK","year":"1992","unstructured":"Gonatas NK, Stieber A, Mourelatos Z, et al.. Fragmentation of the Golgi apparatus of motor neurons in amyotrophic lateral sclerosis. Am J Pathol. 1992, 140:731-7.","journal-title":"Am J Pathol"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1177\/19.6.349","article-title":"Nucleoside diphosphatase and thiamine pyrophosphatase activities in the endoplasmic reticulum and golgi apparatus","volume":"19","author":"Goldfischer S","year":"1971","unstructured":"Goldfischer S, Essner E, Schiller B. Nucleoside diphosphatase and thiamine pyrophosphatase activities in the endoplasmic reticulum and golgi apparatus. J Histochem Cytochem. 1971, 19:349-60. 10.1177\/19.6.349","journal-title":"J Histochem Cytochem"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.3109\/21678421.2015.1070574","article-title":"ALSUntangled No. 30: methylcobalamin","volume":"16","year":"2015","unstructured":"ALSUntangled No. 30. methylcobalamin. Amyotroph Lateral Scler Frontotemporal Degener. 2015, 16:536-9. 10.3109\/21678421.2015.1070574","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/157487-impaired-thiamine-metabolism-in-amyotrophic-lateral-sclerosis-and-its-potential-treatment-with-benfotiamine-a-case-report-and-a-review-of-the-literature","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:02:17Z","timestamp":1707508937000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/157487-impaired-thiamine-metabolism-in-amyotrophic-lateral-sclerosis-and-its-potential-treatment-with-benfotiamine-a-case-report-and-a-review-of-the-literature"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,16]]},"references-count":29,"URL":"https:\/\/doi.org\/10.7759\/cureus.40511","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6,16]]}}}